This inverse relationship between miR-23a-5p and NF-kB signaling was also evident in APL patient’s samples, as assessed by NF-kB target gene expression (CXCL2, CXCL10, IL6) and miR-23a-5p expression (Fig. 1e). The gene discussed is IL6; the disease is acute promyelocytic leukemia.